In a first-in-human study led by Michel Michaelides, MD, gene therapy was evaluated for pediatric patients with AIPL1-associated severe retinal dystrophy. The study demonstrated substantial improvements in visual acuity and functional vision, suggesting the potential of early intervention with gene therapy in protecting against progressive retinal degeneration.

Source: The Lancet